# Teleflex (TFX) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/TFX
## Company Profile
- Ticker: TFX
- Exchange: NYSE
- Sector: MedTech
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 137 USD
- Market cap: 5544401225.639999 USD
- Last updated: 2026-09-08
## Business Overview
Teleflex is a medical technology company with products across anesthesia, vascular access, interventional, and surgical care. Its business is centered on procedure-linked devices used across acute care and hospital settings.
## Why The Stock Is Moving

As of Sep 8, 2026, TFX closed down 0.98% at $137.00. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NYSE, Teleflex has a global medtech footprint. It sits in medical devices rather than biotech or pharma.

## Business Model

The company generates revenue through device sales, consumables, and procedure-related products. Investors focus on hospital demand, product mix, supply execution, and margin trends.

## Landscape Position

Teleflex is outside biotech but important in healthcare technology because it serves procedure-driven clinical workflows. Its stock is driven by device adoption and hospital utilization, not trial data.

## Future Catalysts

- Teleflex’s catalysts are product-cycle execution in connected care and urinary care, plus margin improvement from portfolio simplification. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.

## Recent News
- 2026-01-08 11:30 EST — [Teleflex Announces Leadership Transition](https://biopharmsignal.com/news/TFX/teleflex-announces-leadership-transition-d572754c) — Source: Teleflex
- 2025-12-09 14:04 EST — [Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion](https://biopharmsignal.com/news/TFX/teleflex-announces-sale-of-acute-care-interventional-urology-and-oem-businesses--da92348c) — Source: Teleflex
- 2025-11-14 11:30 EST — [Teleflex to Present at the Jefferies Global Healthcare Conference in London](https://biopharmsignal.com/news/TFX/teleflex-to-present-at-the-jefferies-global-healthcare-conference-in-london-78b44fb9) — Source: Teleflex
- 2025-11-06 11:45 EST — [Teleflex Announces Quarterly Dividend](https://biopharmsignal.com/news/TFX/teleflex-announces-quarterly-dividend-b49b5009) — Source: Teleflex
- 2025-11-06 11:30 EST — [Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook](https://biopharmsignal.com/news/TFX/teleflex-reports-third-quarter-financial-results-and-full-year-2025-outlook-7e2975be) — Source: Teleflex